Liesbeth Hof
Sr. Director PMO
Liesbeth Hof has a Master in Medical Biology with over 20 years of international experiences in the pharmaceutical and biotech industry. During the very early phase of her career, she worked at the ministry of health, after which she moved to Novartis Global in Switzerland and later UK where she worked within global regulatory affairs. Following her time at big pharma she moved to the consultancy organisation ProPharma Group, where she managed a team of consultants and guided start-up and biotech companies in their development programs. Since 2022, she has been working with AM-Pharma, being responsible for the project management of the development programs and operational implementation.
Over the years, Liesbeth drove diverse cross-functional global teams to deliver successful regulatory submissions within different therapeutic areas, including orphan drugs. She also led strategic planning and ensured achievement of major milestones at different stages of the product’s life cycle.
